Business
BIO ESSENCE CORP (OTC Pink: BIOE) Announces Commencement of Regulation A Tier 2 Offering for up to $5.0 Million
BIO ESSENCE CORP (OTC Pink: BIOE) Announces Commencement of Regulation A Tier 2 Offering for up to $5.0 Million.
About this update from Bio Essence Corp.
[{"type":"text","content":"\r\n\r\n \r\n \r\n BIO ESSENCE CORP (OTC Pink: BIOE) Announces Commencement of Regulation A Tier 2 Offering for up to $5.0 Million\r\n \r\n \r\n\r\n\r\nBIO ESSENCE CORP (OTC Pink: BIOE) Announces Commencement of Regulation A Tier 2 Offering for up to $5.0 Million\r\n\r\n\r\n\r\n\r\n\r\nManagement Plans To Take Advantage Of Projected Growth In The AI In Healthcare Market Which Is Projected To Reach USD 505.59 Billion By 2033, Growing At A CAGR Of 38.81% To 2033i\r\n The Company Intends To Use The Net Proceeds From The Offering To Expand Its Existing Core Operations And To Accelerate Its AI-Enabled Health Platform Initiatives IRVINE, CA / ACCESS Newswire / February 3, 2026 / BIO ESSENCE CORP. (the \"Company\" or \"BIOE\" - (OTCID:BIOE): is a company that promotes wellness and vitality through a lifestyle supported by holistic products and practices, and it is pursuing growth strategies that include AI-enabled platform initiatives, today announced that it has commenced its Regulation A, Tier 2 offering of up to $5,000,000 of its securities.\r\n Under the Offering, the Company is offering up to 100,000,000 shares at a public offering price of $0.05 per share, for gross proceeds of up to $5.0 million, before offering-related expenses. The Offering is being conducted pursuant to an offering circular and related offering materials.\r\n CEO, Ms. Yin Yan, JD, MBA, said: \"The Regulation A will provide proceeds and working capital to the Company as we plan to expand into the growing AI-enabled health care initiatives market.\r\n Reports say that the global market for AI-enabled health platforms is experiencing significant growth, with the overall AI in healthcare market projected to reach approximately $36.67 billion in 2025. Specific platform initiatives in areas such as ambient clinical documentation, revenue cycle management, and drug discovery are generating hundreds of millions of dollars in revenue and attracting substantial investment.\r\n The global AI in healthcare market size was valued at USD 26.57 billion in 2024 and is projected to reach USD 505.59 billion by 2033, growing at a CAGR of 38.81% from 2025 to 2033. The key factor driving the growth is the increasing demand in the healthcare sector for enhanced efficiency, accuracy, and better patient outcomes.\r\n The AI in healthcare market in the U.S. is expected to grow signif...